Literature DB >> 25859465

Prescribing Patterns of Drugs in Acute Respiratory Distress Syndrome (ARDS): An Observational Study.

Rahul Magazine1, Shobitha Rao2, Bharti Chogtu3.   

Abstract

INTRODUCTION: Acute respiratory distress syndrome (ARDS) is characterized by acute respiratory failure and is associated with wide range of clinical disorders. Controversy prevails over the pharmacological intervention in this disease. The aim of the study was to observe the prescribing pattern of drugs in patients with ARDS managed at a tertiary care hospital.
MATERIALS AND METHODS: This observational study was conducted at tertiary care hospital in India. Data of patients admitted from January 2010 to December 2012 was collected. Patients aged more than 18 years admitted in ICU, who were diagnosed to have ARDS during the study period, were included. A total of 150 patients of ARDS were selected. Data was collected as per the pre designed proforma and it included patients' age, gender, clinical disorders precipitating ARDS, prescribing pattern of drugs and outcome. The data of the subjects was collected till discharge from hospital or death.
RESULTS: Infection was the cause of ARDS in 81.3% (n=122) of subjects. Antibiotics were prescribed in all the subjects and beta-lactams were prescribed in 97.3% (n=146). 41.3% (n=62) were prescribed corticosteroids, 39.3% (n=59) diuretics and 89.3% (n=134) intravenous fluids.
CONCLUSION: The outcome of patients on different pharmacological treatment did not show any statistically significant difference.

Entities:  

Keywords:  ARDS; Antibiotics; Corticosteroids; Intravenous fluids

Year:  2015        PMID: 25859465      PMCID: PMC4378747          DOI: 10.7860/JCDR/2015/10411.5519

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  31 in total

Review 1.  Glucocorticoids and acute lung injury.

Authors:  B Taylor Thompson
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

2.  Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.

Authors:  Chau-Chyun Sheu; Michelle N Gong; Rihong Zhai; Feng Chen; Ednan K Bajwa; Peter F Clardy; Diana C Gallagher; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2010-05-27       Impact factor: 9.410

3.  Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting.

Authors:  C Iribarren; D R Jacobs; S Sidney; M D Gross; M D Eisner
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

Review 4.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

Review 5.  The role of neuromuscular blockers in ARDS: benefits and risks.

Authors:  Sami Hraiech; Jean-Marie Forel; Laurent Papazian
Journal:  Curr Opin Crit Care       Date:  2012-10       Impact factor: 3.687

6.  Neuromuscular blockers in early acute respiratory distress syndrome.

Authors:  Laurent Papazian; Jean-Marie Forel; Arnaud Gacouin; Christine Penot-Ragon; Gilles Perrin; Anderson Loundou; Samir Jaber; Jean-Michel Arnal; Didier Perez; Jean-Marie Seghboyan; Jean-Michel Constantin; Pierre Courant; Jean-Yves Lefrant; Claude Guérin; Gwenaël Prat; Sophie Morange; Antoine Roch
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

7.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

Review 8.  Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients.

Authors:  J Y Fagon; J Chastre
Journal:  Eur Respir J Suppl       Date:  2003-08

9.  Clinical profile of ARDS.

Authors:  A Vigg; S Mantri; Avanti Vigg; A Vigg
Journal:  J Assoc Physicians India       Date:  2003-09

Review 10.  Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Waleed Alhazzani; Mohamed Alshahrani; Roman Jaeschke; Jean Marie Forel; Laurent Papazian; Jonathan Sevransky; Maureen O Meade
Journal:  Crit Care       Date:  2013-03-11       Impact factor: 9.097

View more
  3 in total

Review 1.  Adjuvants to mechanical ventilation for acute respiratory distress syndrome.

Authors:  Laveena Munshi; Gordon Rubenfeld; Hannah Wunsch
Journal:  Intensive Care Med       Date:  2016-03-29       Impact factor: 17.440

2.  Systematic review of the scrub typhus treatment landscape: Assessing the feasibility of an individual participant-level data (IPD) platform.

Authors:  Kartika Saraswati; Brittany J Maguire; Alistair R D McLean; Sauman Singh-Phulgenda; Roland C Ngu; Paul N Newton; Nicholas P J Day; Philippe J Guérin
Journal:  PLoS Negl Trop Dis       Date:  2021-10-14

3.  Translating Lung Microbiome Profiles into the Next-Generation Diagnostic Gold Standard for Pneumonia: a Clinical Investigator's Perspective.

Authors:  Georgios D Kitsios
Journal:  mSystems       Date:  2018-03-13       Impact factor: 6.496

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.